Navigation Links
Team Finance LLC Announces Fiscal 2008 Financial Results
Date:2/9/2009

31,044 27,703 Earnings from continuing operations 44,666 43,846 Loss from discontinued operations less applicable benefit from income taxes of $363 - (576) Net earnings $44,666 $43,270 Team Finance LLC Financial Highlights (unaudited) For the three months ended December 31, 2008 2007 (In thousands) Net revenues $571,036 $551,071 Provision for uncollectibles 239,527 237,517 Net revenues less provision for uncollectibles 331,509 313,554 Cost of services rendered Professional service expenses 267,379 247,462 Professional liability costs 18,233 13,792 Gross profit 45,897 52,300 General and administrative expenses 28,665 31,165 Management fee and other expenses 856 1,021 Transaction costs 581 - Impairment of intangibles 9,134 - Depreciation and amortization 4,722 3,868 Interest expense, net 11,816 13,804 Gain on extinguishment of debt (1,640) - Earnings (loss) from continuing operations before income taxes
'/>"/>
SOURCE Team Health Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
2. Meth Project Chairman Testifies Before U.S. Senate Finance Committee
3. SEIU Applauds Bipartisan Leadership of Sen. Finance Committee in Push for Greater Oversight of Private Equity Takeovers of Nursing Homes
4. Kerry, Snowe Push Finance Committee on Small Business Health Care
5. Harmony Information Systems Raises $28 Million in Series B Financing from JMI Equity, Updata Partners, ORIX Venture Finance and Comerica Bank
6. OneMedPlace Emerging Healthcare Technologies Finance Forum Jan 7, 8th
7. Cardiva Medical, Inc. Appoints Two New Officers: Malcolm Farnsworth as Vice President of Finance and Chief Financial Officer and Tara Zerby as Vice President of Business Development and Marketing
8. Senate Finance Committee Recommends Ways That Medicare Can Enhance Current Physician Quality Reporting Initiative (PQRI)
9. Bush Budget Represents Double Whammy Hit on U.S. Seniors Medicare-Financed Nursing Facility Care
10. Team Finance LLC Announces Fiscal 2007 Results
11. HealthSouth to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference and the 2008 Credit Suisse Global Leveraged Finance Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...UCW Academy of Health holds open house at Victoria...ocus) November 8, 2009 -- UCW Academy of Health in...Columbia’s health care industry to attend th...25, 2009. , ,UCW Academy of Health, which offers ...and social services, designs its programs to meet ...
(Date:11/8/2009)...New book called "Preventing and Healing AIDS ...raldo shows that AIDS is a result of multiple, rep...ed immune system stressor agents, which can be eit...l, emotional. , Oakland,...; 8, 2009, cell biologists, physicians, chemists a...
(Date:11/8/2009)...PRNewswire-USNewswire/ -- Today, the House of Repr...kemper, Smith, Ellsworth and Lipinski amendment to.... 3962). The amendment maintains the current polic...or benefits packages that include abortion. It cla...fordability credits and those who do not, can with...
(Date:11/8/2009)...sage of H.R. 3961 to Secure the Stability of Medic... -- Statement Attributable to: J. James Rohack, M.... (Logo: http://www.newscom.com/cgi-bin/prnh/2008...of the House health reform bill, which will help i...ns and calls for swift passage of H.R. 3961 to sec...
(Date:11/8/2009)...ov. 8 March of Dimes ho...eon to recognize prominent individuals who are cel...ole models for March of Dimes commitment to improv...imes November Prematurity Awareness Month campaign...n the fight for preemies! ,, (Photo: http://w...
Breaking Medicine News(10 mins):Health News:College Invites Public to Explore Career Options in Health Care 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:Hollywood Stars Joined in a Celebration of Babies 2Health News:Hollywood Stars Joined in a Celebration of Babies 3
...) --,HearAtLast Holdings, Inc. is proud to announc...art Canada (NYSE: WMT ) to open its 16th hearing-...located at 255 Silver Linden,Dr. in Richmond Hill,... its option under a master licensing agreement wit...
...standard being adopted worldwide by, pharmaceutica... confirming digital iden...ms,(Nasdaq: ALDN ), an information security leade... hardware product,to be certified under the recent...
...Diverse Expertise, MIAMI, Dec. 9 Novis Pharmaceu...oducts to healthcare providers, is pleased,to anno...e President of,Human Resources. Ms. Lopez was most...ating from Florida International,University (FIU)....
...eruse of colorectal cancer screening procedures am...n the January 15, 2008 issue of CANCER, a peer-rev... that only 25 percent of Medicare patients receive... States. The American Cancer Society estimates tha...
... believe or disbelieve a statement is a powerful f...t the basis of these states in the brain is not ye...lief and uncertainty activate distinct regions of ... the Annals of Neurology ( http://www.interscience...
...sone improved pre, - and post-stem cell transplan... dexamethasone -, ATLANTA, Dec...M ) reported the presentation of results from an i...nd,dexamethasone (VcTD) to thalidomide and dexamet...
Other Medicine News:Health News:HearAtLast Continues Expansion Announcing Opening of New Clinic Location in Sam's Club in Richmond Hill, Ontario 2Health News:HearAtLast Continues Expansion Announcing Opening of New Clinic Location in Sam's Club in Richmond Hill, Ontario 3Health News:HearAtLast Continues Expansion Announcing Opening of New Clinic Location in Sam's Club in Richmond Hill, Ontario 4Health News:Aladdin eToken First Strong Authentication Device to Achieve Certification from the SAFE-BioPharma Association 2Health News:Aladdin eToken First Strong Authentication Device to Achieve Certification from the SAFE-BioPharma Association 3Health News:Aladdin eToken First Strong Authentication Device to Achieve Certification from the SAFE-BioPharma Association 4Health News:Novis Pharmaceuticals Hires Lisa Lopez 2Health News:Many Medicare beneficiaries not receiving colorectal cancer screening 2Health News:Belief, disbelief and uncertainty activate distinct brain regions 2Health News:Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma 2Health News:Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma 3Health News:Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma 4Health News:Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma 5Health News:Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma 6
(Date:11/6/2009)...M, N.C., Nov. 6 Oxygen B...day announced that a previously approved reverse s...tart of trading on Monday, Nov. 9, 2009 on a 1-for...Inc. shares will trade under the new symbol OXBT. ...P 20 9, when the split becomes effective. ,, "T...
(Date:11/6/2009)...STOWN, N.J., Nov. 6 Wats...specialty pharmaceutical company, announced today ...cutive officer, will provide an overview and updat...8th Annual Healthcare Conference on Wednesday, Nov...,, This presentation will be webcast live and c...
(Date:11/6/2009)...ESTON, S.C., Nov. 6 T...g in South Carolina and Georgia throughout the wee...elp uninsured and financially-struggling patients ...iption medicines for free or nearly free. With the...nt, the Partnership for Prescription Assistance (P...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 2Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 3Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession 2Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession 3Study Shows Otamixaban Substantially Reduced Complications of Invasive Management of Acute Coronary Syndromes 4918 1Study Shows Otamixaban Substantially Reduced Complications of Invasive Management of Acute Coronary Syndromes 4918 2Study Shows Otamixaban Substantially Reduced Complications of Invasive Management of Acute Coronary Syndromes 4918 3Study Shows Otamixaban Substantially Reduced Complications of Invasive Management of Acute Coronary Syndromes 4918 4New Large Scale Global Study Provides Additional Information About an Intensified Dose Regimen of PLAVIX 28R 29 in Acute Coronary Syndrome Patients U 4917 1New Large Scale Global Study Provides Additional Information About an Intensified Dose Regimen of PLAVIX 28R 29 in Acute Coronary Syndrome Patients U 4917 2New Large Scale Global Study Provides Additional Information About an Intensified Dose Regimen of PLAVIX 28R 29 in Acute Coronary Syndrome Patients U 4917 3New Large Scale Global Study Provides Additional Information About an Intensified Dose Regimen of PLAVIX 28R 29 in Acute Coronary Syndrome Patients U 4917 4New Large Scale Global Study Provides Additional Information About an Intensified Dose Regimen of PLAVIX 28R 29 in Acute Coronary Syndrome Patients U 4917 5Get Ready for Ragweed 55647 1Get Ready for Ragweed 55647 2
... Italy, April 26 Schering-Plough Corporation,(NYS...ed interim analysis of,an ongoing Phase II study o... protease inhibitor, in 595 treatment-naive patien... were presented at the 43rd Annual,Meeting of the ...ASL). The,ongoing study evaluates boceprevir in 28...
...Large Study Comparing Leading Hepatitis C Therapie...ide Clinical Practice, MILAN, Italy, April 26 Fi...andomized, clinical study comparing the,leading th...day at the 43rd,Annual Meeting of the European Ass...ing important insights that may help guide clinica...
Other Medicine Technology:Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 2Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 3Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 4Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 5Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 6Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 7Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 8Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 9Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 2Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 3Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 4Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 5Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 6Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 7Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 8Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 9Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 10
...o-Surgery provides clip appliers in 10mm and 5mm s...iers provide precise clip placement., ,The ALLPOR...e preloaded, single-trigger instruments are design... a 5mm trocar, through a 5mm reducer cap in a larg...
...P-HS assay utilizes turbidimetric immunoassay meth...uring over the range of 0.2-28.0 mg/dL. This assay...to most clinical chemistry analyzers. The Wako CRP...ecision, linearity, correlation, and sensitivity. ...
LabDAQ3 Laboratory Information System
...e for laboratories to work more efficiently has ne...e solutions. With the COBAS INTEGRA® 400 plus,...ies, robotic handling of reaction cuvettes and imp...broad menu and ease-of-use required for true workl...
Medicine Products: